Anacor Pharmaceuticals, Inc. et al v. Padagis Israel Pharmaceuticals Ltd. et al
| Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V. |
| Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC |
| 1:2021cv01351 |
| September 24, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 24, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney James W. Sanner for Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
Filing 18
ORDER: These cases are consolidated for all purposes. Civil Action No. 21-1348-CFC shall be designated as the lead case and all future filings shall be made in Lead Case No. 21-1348-CFC ONLY. Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 2/17/2022 at 11:30 AM before Judge Colm F. Connolly.) If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 1/10/2022. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(nmf)
|
| Case associated with lead case: Create association to 1:21-cv-01348-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1348-CFC ONLY. (nmf) |
| Filing 17 Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding request for consolidation of cases - re (14 in 1:21-cv-01349-CFC, 14 in 1:21-cv-01349-CFC, 17 in 1:21-cv-01353-CFC, 17 in 1:21-cv-01353-CFC, 16 in 1:21-cv-01348-CFC, 16 in 1:21-cv-01348-CFC, 15 in 1:21-cv-01351-CFC, 15 in 1:21-cv-01351-CFC, 16 in 1:21-cv-01350-CFC, 16 in 1:21-cv-01350-CFC) Order,,, Set Deadlines,,. (Blumenfeld, Jack) |
| Filing 16 ANSWER to #11 Answer to Complaint, Counterclaim - by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V..(Blumenfeld, Jack) |
|
Filing 15
ORDER: IT IS ORDERED that, on or before January 7, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/7/2022.) Signed by Judge Colm F. Connolly on 12/3/2021. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(nmf)
|
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Steven H. Sklar and James W. Sanner - filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. (Attachments: #1 Certification of Steven H. Sklar, #2 Certification of James W. Sanner)(Bilson, David) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Steven H. Sklar and James W. Sanner, filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC Ordered by Judge Colm F. Connolly on 12/2/2021. (kmd)
|
| Pro Hac Vice Attorney Steven H. Sklar for Padagis Israel Pharmaceuticals Ltd. and Padagis, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Pro Hac Vice Attorneys Elizabeth Chang, Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, and C. Sebastian Zonte for Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC(srs) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Padagis, LLC. (Phillips, John) |
| Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Padagis LLC for Padagis Israel Pharmaceuticals Ltd. filed by Padagis Israel Pharmaceuticals Ltd.. (Phillips, John) |
| Filing 11 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC.(Phillips, John) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang - filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
|
SO ORDERED, re (9 in 1:21-cv-01349-CFC, 12 in 1:21-cv-01348-CFC, 10 in 1:21-cv-01353-CFC, 10 in 1:21-cv-01351-CFC, 10 in 1:21-cv-01350-CFC) MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, Amit H. Thakore, C. Sebastian Zonte and Elizabeth Chang filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 10/14/2021. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (kmd)
|
| Filing 9 STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to November 17, 2021 - filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. (Phillips, John) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to November 17, 2021 filed by Padagis Israel Pharmaceuticals Ltd., Padagis, LLC. Set/Reset Answer Deadlines: Padagis Israel Pharmaceuticals Ltd. answer due 11/17/2021; Padagis, LLC answer due 11/17/2021. Ordered by Judge Colm F. Connolly on 10/12/2021. (kmd)
|
| Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Padagis Israel Pharmaceuticals Ltd. on September 30, 2021, filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V.. (Dellinger, Megan) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01348-CFC, 1:21-cv-01349-CFC, 1:21-cv-01350-CFC, 1:21-cv-01351-CFC, 1:21-cv-01353-CFC (rjb) |
| Filing 7 SUMMONS Returned Executed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc.. Padagis, LLC served on 9/27/2021, answer due 10/18/2021. (Blumenfeld, Jack) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Padagis Israel Pharmaceuticals Ltd. on 9/27/2021; Padagis, LLC on 9/27/2021. (Attachments: #1 Summons)(nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. filed by Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,451 B2; 8,168,614 B2; 8,501,712 B2; 9,682,092 B2. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/17/2021. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: 12/14/2024. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Padagis Israel Pharmaceuticals Ltd., Padagis, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3707114.) - filed by PF PRISM IMB B.V., Anacor Pharmaceuticals, Inc. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
